Effect of gender on transition of normo- to microalbuminuria under angiotensin receptor blocker therapy in diabetes.

Autor: Scurt FG; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Health Campus Immunology, Infectiology and Inflammation, Otto-von Guericke University, Magdeburg, Germany., Menne JJ; Nephrology Section, Hannover Medical School, Hannover, Germany.; Clinic of Nephrology, Angiology and Rheumatology, KRH Klinikum Siloah, Hannover, Germany., Korda A; LVR-Klinikum Düsseldorf, Heinrich, Heine, University Düsseldorf, Düsseldorf, Germany., Haller H; Nephrology Section, Hannover Medical School, Hannover, Germany., Chatzikyrkou C; Clinic of Nephrology, Hypertension, Diabetes and Endocrinology, Health Campus Immunology, Infectiology and Inflammation, Otto-von Guericke University, Magdeburg, Germany.
Jazyk: angličtina
Zdroj: Journal of diabetes [J Diabetes] 2020 Nov; Vol. 12 (11), pp. 856-859. Date of Electronic Publication: 2020 Sep 04.
DOI: 10.1111/1753-0407.13102
Abstrakt: Highlights In normoalbuminuric diabetic patients at low cardiovascular risk, the risk of transition from normo- to microalbuminuria is lower in women, despite the nonprotective effects of the angiotensin receptor blocker olmesartan. Additional methods of assessment of albuminuria in clinical studies (eg, measurements of albumin and creatinine excretion rate) should be implemented or the actually accepted higher urine albumin creatinine ratio (UACR) cutoff values for microalbuminuria in women reconsidered.
(© 2020 Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje